Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: In vitro and in vivo
Open accessPublished version of a preprint
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
SARS-CoV-2 infection in hospital areas is of a particular concern, since the close interaction between health care personnel and patients diagnosed with COVID-19, which allows virus to be easily spread between them and subsequently to their families and communities. Preventing SARS-CoV-2 infection among healthcare personnel is essential to reduce the frequency of infections and outbreaks during the pandemic considering that they work in high-risk areas. In this research, silver nanoparticles (AgNPs) were tested in vitro and shown to have an inhibitory effect on SARS-CoV-2 infection in cultured cells. Subsequently, we assess the effects of mouthwash and nose rinse with ARGOVIT ® silver nanoparticles (AgNPs), in the prevention of SARS-CoV-2 contagion in health workers consider as high-risk group of acquiring the infection in the General Tijuana Hospital, Mexico, a hospital for the exclusive recruitment of patients diagnosed with COVID-19. We present a prospective randomized study of 231 participants that was carried out for 9 weeks (during the declaration of a pandemic). The "experimental" group was instructed to do mouthwash and nose rinse with the AgNPs solution; the "control" group was instructed to do mouthwashes and nose rinse in a conventional way. The incidence of SARS-CoV-2 infection was significantly lower in the "experimental" group (two participants of 114, 1.8%) compared to the "control" group (thirty-three participants of 117, 28.2%), with an 84.8% efficiency. We conclude that the mouth and nasal rinse with AgNPs helps in the prevention of SARS-CoV-2 infection in health personnel who are exposed to patients diagnosed with COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both studies reported large protective effects of the intervention on SARS‐CoV‐2 infection with reported outcomes of SARS‐C0V‐2 infection in 28.2% and 12.7% in the HCWs not using the interventions versus 1.8% and 1.2% in those using the intervention”
From Physical interventions to interrupt or reduce the spread of respiratory viruses (2023) · cites this paper as Almanza-Reyes 2021
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“One study provided insufficient information to enable judgment (Almanza‐Reyes 2021).”
From Physical interventions to interrupt or reduce the spread of respiratory viruses (2023) · cites this paper as Almanza-Reyes 2021
The cited source says what the claim attributes to it.
In the citing paper
“There were no adverse reactions in the study by Almanza‐Reyes 2021 or side effects in the study by Gutiérrez‐García 2022.”
From Physical interventions to interrupt or reduce the spread of respiratory viruses (2023) · cites this paper as Almanza‐Reyes 2021
The cited source says what the claim attributes to it.
In the citing paper
“Almanza‐Reyes 2021 reported the incidence of SARS‐CoV‐2 infection was statistically significantly lower in the silver mouth wash/nose rinse group (two out of 114, 1.8%) compared to the conventional mouthwash group (33 out of 117, 28.2%)”
From Physical interventions to interrupt or reduce the spread of respiratory viruses (2023) · cites this paper as Almanza‐Reyes 2021
The cited source says what the claim attributes to it.
In the citing paper
“Two trials of mouthwash/nose rinse were conducted during the SARS‐cov‐2 pandemic in HCWs: Almanza‐Reyes 2021 compared silver mouth wash/nose rinse versus conventional mouthwashes and nose rinse; and Gutiérrez‐García 2022 compared neutral electrolysed water mouth and nose rinses versus no rinses.”
From Physical interventions to interrupt or reduce the spread of respiratory viruses (2023) · cites this paper as Almanza-Reyes 2021
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735 · cited 1×
“On the other hand, no vaccine has been created so far against any coronavirus causing the last three pandemics such as SARS-CoV in 2002 [16], MERS-CoV in 2012 [17] and SARS-CoV-2 in 2019 [18].”
BackgroundAn mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,406
Transmission routes of 2019-nCoV and controls in dental practice
Peng, X., Xu, X., Li, Y., Cheng, L., Zhou, X., & Ren, B. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0075-9 · Cited by 2,437 · cited 3×
“These results justify making changes to the international recommendations [33] on new dental clinical practices and the prevention of SARS-CoV-2.”
BackgroundResultInfluentialFolegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., Bellamy, D., Bibi, S., Bittaye, M., Clutterbuck, E. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31604-4 · Cited by 2,419
Guan, Y., Zheng, B. J., He, Y. Q., Liu, X. L., Zhuang, Z. X., Cheung, C. L., Luo, S. W., Li, P. H., Zhang, L. J., Guan, Y. J., et al. (2003) · Science · doi:10.1126/science.1087139 · Cited by 2,406
Consistent Detection of 2019 Novel Coronavirus in Saliva
To, K. K.-W., Tsang, O. T.-Y., Yip, C. C.-Y., Chan, K.-H., Wu, T.-C., Chan, J. M.-C., Leung, W.-S., Chik, T. S.-H., Choi, C. Y.-C., Kandamby, D. H., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa149 · Cited by 1,873 · cited 1×
“2 × 10(8) infectious copies / per mL [32].”
BackgroundLogunov, D. Y., Dolzhikova, I. V., Shcheblyakov, D. V., Tukhvatulin, A. I., Zubkova, O. V., Dzharullaeva, A. S., Kovyrshina, A. V., Lubenets, N. L., Grousova, D. M., Erokhova, A. S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00234-8 · Cited by 1,747
Multiple organ infection and the pathogenesis of SARS
Gu, J., Gong, E., Zhang, B., Zheng, J., Gao, Z., Zhong, Y., Zou, W., Zhan, J., Wang, S., Xie, Z., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050828 · Cited by 1,379
Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study.
Ren, L.-L., Wang, Y.-M., Wu, Z.-Q., Xiang, Z.-C., Guo, L., Xu, T., Jiang, Y.-Z., Xiong, Y., Li, Y.-J., Li, X.-W., et al. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000722 · Cited by 1,349 · cited 1×
“On the other hand, no vaccine has been created so far against any coronavirus causing the last three pandemics such as SARS-CoV in 2002 [16], MERS-CoV in 2012 [17] and SARS-CoV-2 in 2019 [18].”
BackgroundZhu, F.-C., Guan, X.-H., Li, Y.-H., Huang, J.-Y., Jiang, T., Hou, L.-H., Li, J.-X., Yang, B.-F., Wang, L., Wang, W.-J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31605-6 · Cited by 1,225
Cited by
Physical interventions to interrupt or reduce the spread of respiratory viruses
Jefferson, T., Dooley, L., Ferroni, E., Al-Ansary, L. A., van Driel, M. L., Bawazeer, G. A., Jones, M. A., Hoffmann, T. C., Clark, J., Beller, E. M., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006207.pub6 · Cited by 291
Duman, H., Eker, F., Akdaşçi, E., Witkowska, A. M., Bechelany, M., & Karav, S. (2024) · Nanomaterials · doi:10.3390/nano14181527 · Cited by 247
“[109] Table 3.”
Silver Nanoparticles: Review of Antiviral Properties, Mechanism of Action and Applications
Luceri, A., Francese, R., Lembo, D., Ferraris, M., & Balagna, C. (2023) · Microorganisms · doi:10.3390/microorganisms11030629 · Cited by 223
“Prevention AgNPs (ArgovitTM) SARS-CoV-2 Prototype [37]”
BackgroundInfluentialRecent developments in the use of gold and silver nanoparticles in biomedicine
Pasparakis, G. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1817 · Cited by 141
Prophylaxis against covid-19: living systematic review and network meta-analysis
Bartoszko, J. J., Siemieniuk, R. A., Kum, E., Qasim, A., Zeraatkar, D., Martinez, J. P. D., Azab, M., Ibrahim, S., Izcovich, A., Soto, G. B., et al. (2021) · BMJ · doi:10.1136/bmj.n949 · Cited by 113
Labulo, A. H., David, O. A., & Terna, A. D. (2022) · Chemical Papers · doi:10.1007/s11696-022-02392-w · Cited by 111
An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19
Yasamineh, S., Kalajahi, H. G., Yasamineh, P., Yazdani, Y., Gholizadeh, O., Tabatabaie, R., Afkhami, H., Davodabadi, F., farkhad, A. K., Pahlevan, D., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01625-0 · Cited by 108
“The results showed that the mouth and nasal rinse by AgNPs assist in the inhibition of COVID-19 in health workers who are exposed to patients detected with SARS-CoV-2 infection [89].”
BackgroundGreen synthesis of iron nanoparticles: Sources and multifarious biotechnological applications
Kumar, V., Kaushik, N. K., Tiwari, S. K., Singh, D., & Singh, B. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127017 · Cited by 120
Rana, A., Pathak, S., Lim, D., Kim, S., Srivastava, R., Sharma, S. N., & Verma, R. K. (2023) · ACS Applied Nano Materials · doi:10.1021/acsanm.3c01351 · Cited by 77
He, Q., Lü, J., Liu, N., Lü, W., Li, Y., Shang, C., Li, X., Hu, L., & Jiang, G. (2022) · Nanomaterials · doi:10.3390/nano12060990 · Cited by 60
“Our results provide insights into the virucidal application of AgNPs to prevent transmission, such as their use in mouthwashes and nasal rinse solutions, as well as in personal protective equipment [46] and into their therapeutic application to treat infected individuals.”
ResultAntimicrobial polymeric composites for high-touch surfaces in healthcare applications
Liu, M., Bauman, L. A., Nogueira, C. L., Aucoin, M. G., Anderson, W. A., & Zhao, B. (2022) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2022.100395 · Cited by 67
Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges
Bai, Z., Wan, D., Lan, T., Hong, W., Dong, H., Wei, Y., & Wei, X. (2024) · ACS Nano · doi:10.1021/acsnano.3c10797 · Cited by 61
Mbatha, L. S., Akinyelu, J., Chukwuma, C. I., Mokoena, M. P., & Kudanga, T. (2023) · Viruses · doi:10.3390/v15030741 · Cited by 57
New insights from nanotechnology in SARS-CoV-2 detection, treatment strategy, and prevention
Solanki, R., Shankar, A., Modi, U., & Patel, S. (2023) · Materials Today Chemistry · doi:10.1016/j.mtchem.2023.101478 · Cited by 52
Al‐Radadi, N. S., & Abu‐Dief, A. M. (2022) · Inorganic and Nano-Metal Chemistry · doi:10.1080/24701556.2022.2068585 · Cited by 60
“By activating pro-inflammatory signaling, which is also involved in lung fibrosis, cytokine storm produces systemic as well as pulmonary inflammation [167,168].”
Frippiat, T., Art, T., & Delguste, C. (2025) · Nanomaterials · doi:10.3390/nano15030202 · Cited by 60
“Anecdotally, the use of daily mouthwash and nose rinse with AgNPs (~15 nm in size) solutions for nine weeks resulted in a lower incidence of SARS-CoV-2 in health workers during the declaration of the pandemic, with an 84.8% efficiency [180].”
InfluentialClinical translation and landscape of silver nanoparticles
Dias, M., Zhang, R., Lammers, T., & Pallares, R. M. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01716-5 · Cited by 40
Ahmed, A. E. T., Dhahi, T. S., Attia, T. A., Ali, F. A. E., Elobaid, M. E., Adam, T., & Gopinath, S. C. B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e41338 · Cited by 39
Al-Hakkani, M. F., Gouda, G. A., Hassan, S. H. A., Mohamed, M. M. A., & Nagiub, A. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-14997-y · Cited by 41
Gil-Korilis, A., Cojocaru, M., Berzosa, M., Gamazo, C., Andrade, N. J., & Ciuffi, K. J. (2023) · Applied Clay Science · doi:10.1016/j.clay.2023.106968 · Cited by 36
The application of nanoparticles as advanced drug delivery systems in Attenuating COPD
Jessamine, V., Mehndiratta, S., Rubis, G. D., Paudel, K. R., Shetty, S. R., Suares, D., Chellappan, D. K., Oliver, B. G. G., Hansbro, P. M., & Dua, K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25393 · Cited by 42
Baselga, M., Uranga-Murillo, I., de Miguel, D., Arias, M. A., Sebastián, V., Pardo, J., & Arruebo, M. (2022) · Materials · doi:10.3390/ma15144742 · Cited by 37
“Although the antiviral mechanism is unknown with precision, colloidal silver has shown high efficiency in the inactivation of the SARS-CoV-2 virus [29,30], presenting better antiviral behavior than other nanostructured metals.”
BackgroundBoas, D., Remennik, S., & Reches, M. (2022) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2022.10.154 · Cited by 33
Martίn-Faivre, L., Prince, L., Cornu, C., Villeret, B., Sánchez-Guzmán, D., Rouzet, F., Sallenave, J., & García-Verdugo, I. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122721 · Cited by 28
Iron oxide and iron oxyhydroxide nanoparticles impair SARS-CoV-2 infection of cultured cells
DeDiego, M. L., Portilla, Y., Daviu, N., López-García, D., Villamayor, L., Mulens‐Arias, V., Ovejero, J. G., Gallo‐Córdova, Á., Veintemillas-Verdaguer, S., Morales, M. P., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01542-2 · Cited by 28
“The antiviral activity of metal and metal oxide NPs has been investigated to combat Dengue virus [20], rotavirus [21], influenza virus [22–24], human immunodeficiency virus 1 (HIV-1) [24] and SARS-CoV-2 [22, 25].”
BackgroundLessons from the history of inorganic nanoparticles for inhalable diagnostics and therapeutics
Uskoković, V. (2023) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2023.102903 · Cited by 27
Silver Nanoparticle‐Mediated Antiviral Efficacy against Enveloped Viruses: A Comprehensive Review
Mosidze, E., Franci, G., Dell’Annunziata, F., Capuano, N., Colella, M., Salzano, F., Galdiero, M., Bakuridze, A., & Folliero, V. (2025) · Global Challenges · doi:10.1002/gch2.202400380 · Cited by 35
Nefedova, E. V., Koptev, V. Y., Bobikova, A. S., Cherepushkina, V., Mironova, T. E., Afonyushkin, V. N., Николаевич, Ш. Н., Донченко, Н. А., Kozlova, Y. N., Sigareva, N. A., et al. (2021) · Veterinary Sciences · doi:10.3390/vetsci8100239 · Cited by 23
“The investigation of blood serum samples collected from 51 healthcare workers of an Italian COVID-19 hospital showed that a higher concentration of C12 was observed in protected workers compared with those infected with SARS-CoV2 [46].”
BackgroundResultSelf-citationAntiviral effects of coinage metal-based nanomaterials to combat COVID-19 and its variants
Mushtaq, A., Iqbal, M. Z., & Kong, X. (2022) · Journal of Materials Chemistry B · doi:10.1039/d2tb00849a · Cited by 23
Tackling COVID‐19 Using Antiviral Nanocoating's—Recent Progress and Future Challenges
Ghosal, K. (2022) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.202200154 · Cited by 23
Pérez‐Caselles, C., Burgos, L., Sánchez-Balibrea, I., Egea, J. A., Faize, L., Martín-Valmaseda, M., Bogdanchikova, N., Pestryakov, A. N., & Alburquerque, N. (2023) · Plants · doi:10.3390/plants12071547 · Cited by 23
“Viricide activity of Argovit® has been demonstrated against Canine distemper virus (CDV) in dogs [14], White spot syndrome virus (WSSV) in shrimp [15], Infectious bronchitis coronavirus (IBV) in chicken [16], Rift valley fever virus (RVFV) in cell cultures and in mouse models [17], and SARS-CoV-2 in preventive treatme…”
MethodSelf-citationSiafaka, P. I., Bülbül, E. Ö., Miliotou, Α. N., Karantas, I. D., Okur, M. E., & Okur, N. Ü. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105381 · Cited by 31
Mast, J., Miert, E. V., Siciliani, L., Cheyns, K., Blaude, M.-N., Wouters, C., Waegeneers, N., Bernsen, R., Vleminckx, C., Loco, J. V., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.161889 · Cited by 25
Luceri, A., Francese, R., Perero, S., Lembo, D., Ferraris, M., & Balagna, C. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c13843 · Cited by 24
Ivanoska-Dacikj, A., Oguz, Y., Hossain, G., Kaplan, M., Sivri, Ç., Ros‐Lis, J. V., Mikučionienė, D., Munir, M. U., Kızıldağ, N., Ünal, S., et al. (2023) · Healthcare · doi:10.3390/healthcare11081115 · Cited by 25
“[49].”
A Comparative Study of Cancer Cells Susceptibility to Silver Nanoparticles Produced by Electron Beam
Plotnikov, E. V., Tretayakova, M. S., Garibo-Ruíz, D., Rodríguez‐Hernández, A. G., Pestryakov, A. N., Toledano‐Magaña, Y., & Bogdanchikova, N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030962 · Cited by 19
Self-citationSilver and Silver Nanoparticles for the Potential Treatment of COVID-19: A Review
Arjun, P. N. J., Sankar, B., Shankar, K. V., Kulkarni, N. V., Sivasankaran, S., & Shankar, B. (2022) · Coatings · doi:10.3390/coatings12111679 · Cited by 19
“SHEPROS, a Malaysian company, developed a suspension named ‘Nanosilver sanitizer’ [141] using AgNPs of a size ~25 nm, which is assured to destroy a wide variety of microorganisms and viruses.”
BackgroundThe effect of mouthrinses on severe acute respiratory syndrome coronavirus 2 viral load
Silva, A., Azevedo, M. J., Sampaio‐Maia, B., & Sousa‐Pinto, B. (2021) · The Journal of the American Dental Association · doi:10.1016/j.adaj.2021.12.007 · Cited by 19
“5 (49-88) y; H2O2 þ CHX (n 1⁄4 12), 53 (40-72) y.”
Gupta, G. S., Hamawandi, B., Sheward, D. J., Murrell, B., Hanke, L., McInerney, G. M., Blosi, M., Costa, A. L., Toprak, M. S., & Fadeel, B. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1083232 · Cited by 17
“On the other hand, PVP- or PEG-modified Ag NPs, failed to block virus infection in the present model, though it is notable that a recent study in which health workers were instructed to perform a mouth and nasal wash using PVP-coated Ag NPs suggested a protective effect against SARS-CoV-2 infection (Almanza-Reyes et a…”
ResultIvanova, N. A., Sotirova, Y., Gavrailov, G., Nikolova, K. T., & Andonova, V. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030530 · Cited by 18
Araste, F., Bakker, A. D., & Zandieh‐Doulabi, B. (2023) · Journal of Nanoparticle Research · doi:10.1007/s11051-023-05867-3 · Cited by 18
“As silver nanoparticles (AgNPs) inhibited SARS-CoV-2 in pre-clinical studies [22, 23], they may have potential for wider application.”
BackgroundKarthik, C., Punnaivalavan, K. A., Prabha, S., & Caroline, D. G. (2022) · International nano letters. · doi:10.1007/s40089-022-00367-z · Cited by 15
Idrees, M. M., McGowan, B., Fawzy, A., Abuderman, A., Balasubramaniam, R., & Kujan, O. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912148 · Cited by 14
Ebrahimi, T., Shamshiri, A. R., Alebouyeh, M., & Mohebbi, S. Z. (2023) · BMC Oral Health · doi:10.1186/s12903-023-03126-4 · Cited by 17
“(2021) [38] Viral load or Ct value changes of participants was not reported”
BackgroundDisinfection and decontamination in the context of SARS‐CoV‐2‐specific data
Cimolai, N. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27959 · Cited by 13
“In a randomized trial of a silver nanoparticle suspension for oral and nasal rinsing and prevention, some early success was reported.(184) Another study showed a”
BackgroundGastelum-Leyva, F., Jasso, A. P., Alvarado-Vera, M., López, I. P., Romero, L. P., Loera‐Castañeda, V., Mireles, J. A. G., Lares‐Asseff, I., Leal-Ávila, M. Á., Alvelais-Palacios, J. A., et al. (2022) · Viruses · doi:10.3390/v14112329 · Cited by 18
“The neutralizing activity of AgNPs (Argovit-C) has been characterized in vitro and in vivo against different viruses in preclinical studies with Rift Valley fever virus [52], in infectious bronchitis coronavirus in chickens [53] and, recently, in human clinical studies against the SARS-CoV-2 virus [54].”
BackgroundSelf-citationPotential of Azadirachta indica as a Capping Agent for Antiviral Nanoparticles against SARS‐CoV‐2
Foka, F. E. T., Manamela, N., Mufamadi, M. S., & Mufhandu, H. T. (2022) · BioMed Research International · doi:10.1155/2022/5714035 · Cited by 13
“Almanza-Reyes and colleagues demonstrated that silver nanoparticles (Ag NPs) were able to inhibit SARS-CoV-2 infection both in vitro and in vivo among randomized healthcare personnel [43].”
Bai, A. D., Jiang, Y., Nguyen, D. L., Lo, C. K. L., Stefanova, I. Z., Guo, K., Wang, F., Zhang, C., Sayeau, K., Garg, A., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.53301 · Cited by 16
Nanomedicine and nanoparticle-based delivery systems in plastic and reconstructive surgery
Solidum, J. G. N., Ceriales, J. A., Ong, E. P., Ornos, E. D. B., Relador, R. J. L., Quebral, E. P. B., Lapeña, J. F. F., Tantengco, O. A. G., & Lee, K. Y. (2023) · Maxillofacial Plastic and Reconstructive Surgery · doi:10.1186/s40902-023-00383-9 · Cited by 15
“[54] have shown in vivo that silver nanoparticles have an inhibitory effect on SARS-CoV-2 infection in cultured cells.”
BackgroundResultInfluentialEfficacy of different mouthwashes against COVID-19: A systematic review and network meta-analysis
Sbricoli, L., Schiavon, L., Brunello, G., Brun, P., Becker, K., & Sivolella, S. (2023) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2023.09.003 · Cited by 11
“Contact times above 5 min and up to 72 h were reported in a minority of the studies [103,106,114,115].”
BackgroundKhan, M. U., Aslam, H., Sohail, M. J., Umar, A., Ullah, A., & Ullah, H. (2025) · Discover Oncology · doi:10.1007/s12672-025-02714-w · Cited by 11
Recent advances of nanotechnology in COVID 19: A critical review and future perspective
Chaudhary, K. R., Kujur, S., & Singh, K. (2022) · OpenNano · doi:10.1016/j.onano.2022.100118 · Cited by 14
Iqbal, R., Khan, S., Ali, H. M., Khan, M., Wahab, S., & Khan, T. (2022) · Frontiers in Nanotechnology · doi:10.3389/fnano.2022.1060756 · Cited by 12
Viricidal Activity of Thermoplastic Polyurethane Materials with Silver Nanoparticles
Díaz‐Puertas, R., Rodríguez-Cañas, E., Belló-Pérez, M., Fernández-Oliver, M., Mallavia, R. M., & Falcó, A. (2023) · Nanomaterials · doi:10.3390/nano13091467 · Cited by 11
“Recently, the ability of AgNPs to inhibit SARS-CoV-2 has been investigated [27,28].”
BackgroundEffectiveness of mouth rinses against COVID-19: a systematic review and network meta-analysis
Lin, S., Sun, J., Hung, M.-C., & Chang, J. Z.-C. (2023) · Journal of Hospital Infection · doi:10.1016/j.jhin.2023.06.022 · Cited by 12
“Onlythree trials (two RCTs [43,44] and one NRCT [45]) evaluated the prevention of SARS-CoV-2 infection with prophylactic mouth rinse.”
BackgroundMethodInfluentialSilver Nanoparticles: Biomedical Applications and Future Perspectives
Ranjbar, S., Bakhtiari, A., Khosravi, N., Ashkavandi, S. J., Azamian, F., Alijaniha, M., & Karbalaee, M. (2024) · Journal of Composites and Compounds · doi:10.61186/jcc.6.3.2 · Cited by 9
Pérez‐Caselles, C., Alburquerque, N., Faize, L., Bogdanchikova, N., García‐Ramos, J. C., Rodríguez‐Hernández, A. G., Pestryakov, A. N., & Burgos, L. (2022) · Horticulturae · doi:10.3390/horticulturae8100855 · Cited by 12
Self-citationRole of Nanomaterials in COVID-19 Prevention, Diagnostics, Therapeutics, and Vaccine Development
Patel, U., Rathnayake, K., Hunt, E. C., & Singh, N. (2022) · Journal of Nanotheranostics · doi:10.3390/jnt3040011 · Cited by 9
“Silver NPs SARS-CoV2 Interfere with the structural proteins of the virus by inhibiting their ability to bind with cell receptors In vitro In vivo Inhibitory effect on SARS-CoV-2 infectivity [138]”
BackgroundNanodelivery of antiretroviral drugs to nervous tissues
Lawal, S. K., Olojede, S. O., Faborode, O. S., Aladeyelu, O. S., Matshipi, M. N., Sulaiman, S. O., Naidu, E. C., Rennie, C. O., & Azu, O. O. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1025160 · Cited by 8
“A recent study has reported the potential benefits of using AgNPs as a treatment against SARS-CoV-2 because the metallic aspect of the nanoparticles interferes with the structural protein of SARS-CoV-2, thereby inhibiting it from binding to genetic material and preventing its replication (Das et al., 2020; Almanza-Rey…”
BackgroundAntiviral effect of oral antiseptic solutions commonly used in dentistry practice: A scoping review
Toschi, E. M., Mercado, L. W., & Henz, S. L. (2023) · Dentistry Review · doi:10.1016/j.dentre.2023.100064 · Cited by 7
Castañeda-Yslas, I. Y., Torres-Bugarı́n, O., Arellano-García, M. E., Ruíz-Ruíz, B., García‐Ramos, J. C., Toledano‐Magaña, Y., Pestryakov, A. N., & Bogdanchikova, N. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21121689 · Cited by 6
Self-citationChen, H.-T., Huang, M.-C., Chiang, Y.-Y., Chang, Y. K., Wang, Y., & ching, W. C. (2021) · Materials Advances · doi:10.1039/d4ma00650j · Cited by 6
Ting, M., Dahlkemper, A., Schwartz, J. J., Woodfork, M., & Suzuki, J. B. (2023) · Biomedicines · doi:10.3390/biomedicines11061694 · Cited by 6
Utilización de nanopartículas de plata en la micropropagación de plantas
Bello, J., & Spinoso‐Castillo, J. L. (2022) · Mundo Nano Revista Interdisciplinaria en Nanociencia y Nanotecnología · doi:10.22201/ceiich.24485691e.2023.30.69692 · Cited by 13
Silva, J. M. C., & dos Reis, A. C. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127768 · Cited by 5
Silver Nanoparticles Based Functional Materials for Anti-bacterial and Antiviral Applications
Natarajan, A., Singh, K. R., Singh, P., Singh, J., Pandey, S. S., & Singh, R. P. (2024) · ACS symposium series · doi:10.1021/bk-2024-1472.ch006 · Cited by 5
Antiviral Activity of Graphene Oxide–Silver Nanocomposites Against Murine Betacoronavirus
Cymerys, J., Bartak, M., Słońska, A., Lange, A., Jaworski, S., Chodkowski, M., Ostrowska, A., Wierzbicki, M., Sawosz, E., & Bańbura, M. W. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s473448 · Cited by 5
In vitro antiviral effect of silver nanoparticles against SARS-CoV-2
Flórez‐Álvarez, L., Hernández, J. C., Zapata, W., Charry-Zuluaga, J. I., Jaramillo, J. R., Taborda, N. A., González, J. D. R., Rosado, L. L. M., & Yasssin-Noreña, L. M. (2022) · IATREIA · doi:10.17533/udea.iatreia.188 · Cited by 5
Santos, J. A. O., Martin, C. S., Fulindi, R. B., da Costa, P. I., Pires, A. M., Cebim, M. A., & Lima, S. A. M. (2023) · Optical Materials X · doi:10.1016/j.omx.2023.100281 · Cited by 11
Hypothetical Mechanism of Skin Argyria
Бурмистров, В. А., Бурмистров, А. В., Odegova, G. V., Pestryakov, A. N., Luna-Vázquez-Gómez, R., & Bogdanchikova, N. (2022) · Coatings · doi:10.3390/coatings12040532 · Cited by 5
Self-citationAdedara, I. A., Ileola‐Gold, A. V., Adelaja, U. A., Njoku, C. A., Ikeji, C. N., Owoeye, O., & Farombi, E. O. (2023) · Environmental Toxicology · doi:10.1002/tox.23945 · Cited by 5
Bogdanchikova, N., de León, J. N. D., Farías, M. H., Flores, G. A. H., Corral, M. Á. P., Pestryakov, A. N., & Garibo, D. (2025) · Nano-Structures & Nano-Objects · doi:10.1016/j.nanoso.2025.101601 · Cited by 4
Self-citationEffective Foot‐and‐Mouth Disease Virus Control Using Silver Nanoparticles
Dung, T. T. N., Yên, N. T., Quang, Đ. V., Cong, N. T., Lai, T. N. H., & Le, V. P. (2024) · ChemistrySelect · doi:10.1002/slct.202400143 · Cited by 4
Functional Biomaterials and Biomaterial Composites with Antimicrobial Properties
Luong, J. H. T. (2024) · Journal of Functional Biomaterials · doi:10.3390/jfb15090267 · Cited by 4
“A few examples include mouthwash and nose rinse with AgNP solution, topical silver nanoparticles for microbial activity [9], zinc oxide nanoparticles for the treatment of fungal feet infection [10], ferumoxytol nanoparticles as an antibiofilm treat-ment [11], a novel respirator with chitosan…”
BackgroundNanomaterials as a Versatile Tool for COVID-19 Treatment
Zeinali, S., Moafian, Z., Arshad, R., Karimi, F., Zeinalilathori, S., Rahdar, A., Fathi‐karkan, S., & Pandey, S. (2024) · BioNanoScience · doi:10.1007/s12668-024-01538-2 · Cited by 4
“Over the course of nine weeks, this prospective, randomized trial involving 231 participants discovered that the group treated with AgNP products experienced a substantial reduction in infections (1.8% vs. 28.2% in the control group), demonstrating an efficacy of 84.8% in halting transmission [84].”
InfluentialNanobiotechnology for efficient plum pox virus elimination from apricot plants
Pérez‐Caselles, C., Alburquerque, N., Martín-Valmaseda, M., Alfosea-Simón, F. J., Faize, L., Bogdanchikova, N., Pestryakov, A. N., & Burgos, L. (2024) · Plant Science · doi:10.1016/j.plantsci.2024.112358 · Cited by 3
Self-citationBiosynthesis of Silver Nanoparticles on Polypropylene Nonwovens: towards Antimicrobial Protection
Marković, D., Tomšič, B., Zille, A., Ribeiro, A. I., Tomic, T. I., Tadić, V., Simončić, B., & Radetić, M. M. (2025) · ChemistrySelect · doi:10.1002/slct.202500376 · Cited by 3
Bauer, A. N., Williams, J. F., Pokhrel, L. R., Garcia, S., Majumdar, N., Eells, J. B., Cook, P., & Akula, S. M. (2024) · Toxics · doi:10.3390/toxics12070495 · Cited by 3
“As research continues to progress in this field, nanomedicines such as SNAT may hold promise for combating current and future viral outbreaks.”
BackgroundProperties of AgNPs stabilized with polyvinylpyrrolidone relevant to antidiabetic agents
Pineda, V. V., de la Paz, A. A., Bogdanchikova, N., Pestryakov, A. N., Acevedo‐Fernández, J. J., & Campos, M. R. S. (2025) · Nanoscale · doi:10.1039/d5nr03452c · Cited by 2
Self-citationKaraduman, F. R., Köksal, B. Ö., Metin, A. Ü., & Horzum, N. (2025) · Macromolecular Rapid Communications · doi:10.1002/marc.202401033 · Cited by 3
Use of Nanoparticles to Combat COVID-19
Kumar, A., & Thakur, A. (2021) · Advances in chemical and materials engineering book series · doi:10.4018/978-1-7998-8936-6.ch018 · Cited by 2
Banerjee, T., Frazier, C., Koti, N., Yates, P., Bowie, E., Liermann, M., Johnson, D. K., Willis, S. H., & Santra, S. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c05966 · Cited by 1
Zaczek-Moczydlowska, M. A., Kopyciński, B., Hryniszyn, A., Osadnik, M., Czech, A., Pęcak, K., Markowska, A., Ghavami, S., Matus, K., Langer, E., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211068 · Cited by 1
“Recent research has demonstrated that AgNP serve as effective antiviral agents, successfully evaluated against various viruses both in vitro and in vivo [10,13–16].”
Silver nanoparticles in mouthwashes against infection caused by SARS-CoV-2: a scoping review
Molena, K. F., Martins, C. R. O. G., de Oliveira, C. A. F., Feres, M. F. N., & de Queiroz, A. M. (2023) · Brazilian Dental Science · doi:10.4322/bds.2023.e3721 · Cited by 2
“Considering mouthwash as agents that can reduce the viral load of SARS-CoV-2 in the fight against the COVID-19 [10,16] pandemic is an extremely important concept to be taken into account [10,17].”
BackgroundDave, R. D. (2023) · Journal of Dental Panacea · doi:10.18231/j.jdp.2023.034 · Cited by 2
Silver nanoparticles for treatment of COVID-19 and other viral diseases
Ayipo, Y. O., Badeggi, U. M., Jimoh, A. A., & Mordi, M. N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15343-3.00013-9 · Cited by 1
Usos de las nanopartículas de plata (AgNPs) en odontología
Tapia, V. G., Hamdan‐Partida, A., Sánchez‐Pérez, L., Martínez-Ruíz, F. J., & Bustos‐Martínez, J. (2024) · Mundo Nano Revista Interdisciplinaria en Nanociencia y Nanotecnología · doi:10.22201/ceiich.24485691e.2024.33.69816 · Cited by 5
Metal-based nanomedicines and their immunoregulatory effects
Liu, H., Cao, M., & Chen, C. (2025) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2024-1219 · Cited by 3
“同样 , 在一项临床试验中 , 用 Ag NPs 漱口和鼻腔清洗可预防接触 SARS-COV-2 确 诊患者的医护人员感染 [112] .”
Silver nanoparticles enhance neutron radiation sensitivity in cancer cells: An in vitro study
Plotnikov, E. V., Drozd, A. G., Artamonov, A. A., Larkina, M. S., Белоусов, М. В., Lomov, I. V., Garibo, D., Pestryakov, A. N., & Bogdanchikova, N. (2025) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2025.102813 · Cited by 1
Self-citationProceedings of the Inter Disciplinary Conclave (IDC)-2021
Levy, G. A. (2021) · Journal of Stem Cells and Regenerative Medicine · doi:10.46582/jsrm.1702011
Mass Spectrometry of Nanoparticles
Mašić, A., Bektešević, J., Bibić, D., Mehuljić, M., & Pikula, B. (2021) · Annals of DAAAM for ... & proceedings of the ... International DAAAM Symposium · doi:10.2507/32nd.daaam.proceedings.021
Ramos, B. D. T., Samaniego, B. A. E., & Cordero, J. J. A. (2022) · Research Society and Development · doi:10.33448/rsd-v11i14.36655
Thao, L. Q., Phuong, V. H., Tuan, T. Q., Hoa, N. Q., Hiep, V. V., Vu, L. V., Nhat, H. N., Dinh, N. N., & Thien, N. D. (2023) · MATERIALS TRANSACTIONS · doi:10.2320/matertrans.mt-mg2022029
Challenges for the food industry in controlling the transmission of SARS-CoV-2
Noreña, C. P. Z., & Brandelli, A. (2023) · Journal of Consumer Protection and Food Safety · doi:10.1007/s00003-023-01446-9
Optimizing the Antimicrobial Effects by using Natural Compounds in COVID-19 Management
Gasmi, A., Benahmed, A. G., Dadar, M., Mujawdiya, P. K., & Bjørklund, G. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673294083240520044158
Comparative Effects of Ionic and Nanoparticulate Silver on Nematodes C. elegans and Mice
Magazenkova, D. N., Farroukh, M. A., Samuseva, P. D., Mekhova, A. A., Sankova, T. P., Shchukina, A. D., Baikina, S. A., Sosnin, I. M., Rozhina, E. V., Puchkova, L. V., et al. (2025) · Reviews on advanced materials and technologies · doi:10.17586/2687-0568-2025-7-2-114-123
Nitric Oxide in the Treatment of COVID‐19: Nasal Sprays, Inhalants and Nanoparticles
Wright, A., McGrowder, D. A., & Bryan, S. (2025) · Biochemistry Research International · doi:10.1155/bri/8846903
“Although the mechanism for reducing infectivity was unknown, it was proposed that inhibition of the attachment of SARS-CoV-2 viral proteins to host cell receptors as well as to viral genetic material could be a possible mechanism of action [80].”
Nano-Chitosan and Nanomedicine Approaches Against Pathogenic Coronaviruses
Perveen, I., Hussain, W., Khalid, M. J., Nazir, S., Mumtaz, A., Saleem, Y., Sabahat, S., Najeeb, M., Hameed, S., Faridi, T. A., et al. (2025) · Atlantic Journal of Life Sciences · doi:10.71005/rqx9tt78
Metallic nanoparticle-based strategies for COVID-19 management in the post-pandemic era
Pilaquinga, F., Chuisaca-Londa, E., & Izquierdo, I. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33002-5.00012-9
COVID-19 drug delivery: Current achievements and the impact of nanocarriers
Jayashree, S., Sonia, K., Gopal, M., Sharmili, S. A., & Vijayakumar, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33002-5.00023-3
Metadata
- Authors
- Almanza-Reyes, H., Moreno, S., Plascencia-López, I., Alvarado-Vera, M., Patrón-Romero, L., Borrego, B., Reyes-Escamilla, A., Valencia-Manzo, D., Brun, A., Pestryakov, A., & Bogdanchikova, N.
- Affiliations
- Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (ES)
- Universidad Iberoamericana (MX)
- Tomsk Polytechnic University (RU)
- Universidad Nacional Autónoma de México (MX)
- Corresponding author
- Almanza-Reyes, Horacio
- Moreno, Sandra
- Alvarado-Vera, Martha
- Borrego, Belén
- Reyes-Escamilla, Alberto
- Valencia-Manzo, Daniel
- Brun, Alejandro
- Pestryakov, Alexey
- Bogdanchikova, Nina
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-08-19
- Volume
- 16
- Issue
- 8
- Pages
- e0256401
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC8375774
- OpenAlex
- W3193999063
- Cited by
- 102
- References
- 40
- Citations by year
- 2026: 1 · 2025: 18 · 2024: 20 · 2023: 27 · 2022: 30 · 2021: 6
- FWCI
- 6.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Tomsk Polytechnic University (Development Program "Priority 2030")
- Topics
- Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Infection Control and Ventilation
- Keywords
- silver nanoparticles, SARS-CoV-2, COVID-19 prevention, healthcare workers, mouthwash, infection control, nosocomial infections, antiviral activity
- MeSH terms
- COVID-19, SARS-CoV-2, Adolescent, Adult, Aged, Animals, Chlorocebus aethiops, Female, Health Personnel, Humans, Male, Mexico, Middle Aged, Mouthwashes, Silver, Vero Cells, Metal Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.